FDA Approved: PREVYMIS — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved PREVYMIS (letermovir) from Merck for prophylaxis of cytomegalovirus infection in CMV-seropositive adults receiving an allogeneic hematopoietic stem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• PREVYMIS (letermovir)

Snippet

ORIG AP for PREVYMIS (LETERMOVIR)